BHC
Bausch Health Cos., Inc.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$5.67
+0.35%Next report
Analyst consensus
- Next report date
- Oct 28, 2026
- EPS estimate
- $1.26
- Revenue estimate
- $2.8B
Latest reported
- Last report date
- Jul 29, 2026
- EPS actual
- $1.26
- EPS estimate
- $0.96
- Revenue actual
- $2.8B
- Revenue estimate
- $2.6B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +6.5%
- Revenue beats (12Q)
- 8
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 29, 2026 | $0.96 | $1.26 | Beat 31.25% | $2.8B |
| Apr 29, 2026 | $0.81 | $0.78 | Miss -3.11% | $2.5B |
| Feb 18, 2026 | $1.21 | $1.08 | Miss -10.74% | $2.8B |
| Oct 29, 2025 | $1.07 | $1.16 | Beat 8.41% | $2.7B |
| Jul 30, 2025 | $0.97 | $0.90 | Miss -7.22% | $2.5B |
| Apr 30, 2025 | $0.83 | $0.59 | Miss -28.92% | $2.3B |
| Feb 19, 2025 | $1.65 | $1.15 | Miss -30.30% | $2.6B |
| Aug 1, 2024 | $0.88 | $0.89 | Beat 1.14% | $2.4B |
| May 2, 2024 | $0.75 | $0.59 | Miss -21.33% | $2.2B |
| Feb 22, 2024 | $1.01 | $1.15 | Beat 13.86% | $2.4B |
| Nov 2, 2023 | $0.92 | $1.03 | Beat 11.96% | $2.2B |
| Aug 3, 2023 | $0.75 | $0.81 | Beat 8.00% | $2.2B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 28, 2026